was needed within the common market, both to level the playing field and to limit animal testing. Since then, and revised and strengthened as Directive 2010/63/EU, the EU requires that practically available alternatives to animal experiments have to be used (European Parliament, 2010 (Hartung, 2010a (Daneshian et al., 2015) , according to statistics from the EU and elsewhere; yet, it is probably fair to say that go% of the work to develop alternative methods, in the sense of one-for-one replacement, has taken place in this field (see Stephens and Mak, 2013) (Hartung, 2017a, b ) . Animal experimentation is resource intensive, in terms of both expense and duration (Bottini and Har tung, 2009 ), and we are increasingly realizing the limited predictivity of animal models for humans based on both the limited reproducibility of their results, and the differing results across animal species (Hartung, 2013; Pound et al., 2004; Pound and Bracken, 2014) . Humans are obviously not 70kg rats (Hartung, 2009a (Begley and Ellis, 2012) and in about 20%-25°/o of 67 studies (Prinz, Schlange and Asadullah, 2011) . This and similar findings have fueled a more general discussion about the reproducibility crisis in science (Baker, 2016 (Arrowsmith, 2011a (Arrowsmith, , b, 2012 fail in later stages of drug development when assessed in human trials (Hartung, 2013) . To be sure, the drug development process continues to deliver new entities but at costs in the billion us dollar range (DiMasi, Grabowski and Hansen, 2016) (DiMasi et al., 2016 (Marx et al., 2016) and quality assurance tools (Coecke et al., 2005) (Andersen et al., 2014; Marx et al., 2016; Smirnova et al., 2018) , with more meaningful functional organ models, overcoming many of the shortcomings of traditional cell culture and, thereby, making them more competitive to animal experimentation. Our own development of human mini-brains from stem cells m ay serve as an example for the many models mushrooming as a consequence of stem-cell technologies and advances in bioengineering.
Validating Animal Models and Their Alternatives
The ultimate quality control and the basis for replacing an animal method is formal validation of alternative methods (Leist et al., 2012 (Hoffmann and Hartung, 2006) , with systematic reviews of the litera ture (Stephens et al., 2016) . , but the extent of its applica bility and how to conduct and report it are under debate. This has prompted the development of Good Read-Across Practices (Ball et al., 2016) and ideas for a more automated read-across . The latter development also makes use of the emerging large toxicological databases . These machine-learning approaches are agnostic to the biological effect studied and are similarly useful in drug discovery. Other in silico approaches, which are mushrooming, include modeling from receptor binding to cells, or gans, and organisms. In short, the informatics revolution fuels the replacement of animal tests with increasing pace (Ekins, 2014) . Increasingly, in vitro and in silico methods are combined, forming integrated testing strategies, acknowledging that one method alone does not satisfy all information needs (Hartung et al., 2013; Rovida et al., 2015a) . While the idea is rather simple, the systematic composition, optimization, and validation of Kathrin Herrmann and Kimberley Jayne -978-90-04-39119-2 Downloaded from Brill.com11 /11 /2019 09:57:0BPM via free access such strategies are still in their infancy. Again, the safety sciences are spear heading the concept, also combining it with a more mechanistic approach (Tollefsen et al., 2014) (Langley et al., 2015) . (Hartung et al., 2012 , Smimova et al., 2018 . The scientific progress that is demanding more tailored experimental systems has been automatically making animal testing superflu ous to needs (Rovida et al., 2015b ) . Figure 28 .1 illustrates these developments. Scientifi,c Revolutions (1962) , Thomas Samuel Kuhn (1922 -1996 laid out some principles that nurture this expectation (Hartung, 2008) . Our current belief system is being shattered by, among other things, the reproducibility crisis. Kuhn (1962) 
